| Name | Title | Contact Details |
|---|
Pyro Brand Development is a Dallas, TX-based company in the Business Services sector.
Democracy International is a Bethesda, MD-based company in the Business Services sector.
Adobe Financial Corp is a Mesa, AZ-based company in the Business Services sector.
Cohn & Wolfe, a global communications agency, builds brands and corporate reputations through an uncompromising commitment to creativity. The agency’s strategic approach unearths fresh, relevant insights leading to communications solutions that deliver measurable business success. Throughout its 45-year history, Cohn & Wolfe’s world-class integrated marketing communications have attracted top brands around the world, winning awards at the Cannes Lions, the Clios, Eurobest, the Global SABREs and the Global PRWeek Awards. Headquartered in New York, Cohn & Wolfe has more than 50 offices across Asia, EMEA, Latin America and North America, and has been named Agency of the Year by The Holmes Report and ICCO, as well as a Best Place to Work by The Holmes Report, PRWeek and PRNews. Cohn & Wolfe is part of WPP, the world`s largest communications services group.
Balt is a global medical device manufacturer that specializes in neurovascular and peripheral vascular interventions. Founded in 1977 by Leopold Płowiecki in Montmorency, France, the company has expanded significantly and now operates in over 100 countries with approximately 500 employees. Its U.S. subsidiary, BALT Group, is based in Irvine, California, and is recognized as a certified Great Place to Work. Balt develops a wide range of high-technology devices aimed at treating ischemic and hemorrhagic strokes, as well as peripheral embolization. The company offers the world’s broadest portfolio of neurovascular devices, including microcatheters, intracranial stents, embolization coils, flow diverters, and thrombectomy devices. Balt emphasizes research and development, holding 15 patents related to medical device design and data privacy, with a mission to enhance stroke treatment accessibility and improve patient outcomes globally.